Question 1

What are the potential side effects of using this topical treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the application process look like on a daily basis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to use the treatment to see results?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks involved in participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience an adverse reaction?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) clinical trial (NCT01031901). Contact the study team or your healthcare provider for specific answers.

What this study is about